CICC Capital Leads RMB1 Billion Round In Cancer Screening Firm
December 16, 2020 — 05:01 CST
This Data Is Locked!
This area is available only to Subscribers.
Shanghai Singlera Genomics, a genetic early cancer screening company, has completed nearly RMB1 billion yuan in Series B financing. This round of financing was led... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals